Pharmaceutical CMC strategy and drug development planning in a modern laboratory
CMC Strategy

Dynamics Reshaping Expectations for CMC Strategy and Execution

Thermo Fisher Scientific Pharma Services
CMC Strategy

A coordinated approach connecting clinical strategy, CMC, manufacturing and supply planning.

Kevin Kane, PhD, CMC Strategy Director, shares insight on AI-assisted development, phase-appropriate supply strategies and coordinated clinical, CMC and manufacturing decision-making.

Kevin Kane, PhD, CMC Strategy Director, shares insight on AI-assisted development, phase-appropriate supply strategies and coordinated clinical, CMC and manufacturing decision-making.

AI-Assisted Development

AI is being applied to formulation screening, process optimization, analytical method development and submission preparation, accelerating timelines while improving robustness.

Phase-Appropriate Supply Strategies

Not every stage needs the same CMC investment. Phase-appropriate strategies balance speed and cost early while building the foundation for late-stage success.

Coordinated Decision-Making

Integrated project teams that bring together clinical, CMC and manufacturing expertise make better decisions faster and avoid downstream surprises.

Download This White Paper

Biotechnology Media Insights

Continue to Biotechnology Media Insights to access this white paper.

Pharmaceutical & Biotechnology White Papers | Biotechnology Media Insights